SanBio, Inc. is a biopharmaceutical startup founded in February 2001, with a mission to develop regenerative medicines for patients and value for stakeholders. The company focuses on using regenerative cell medicine to treat disabilities caused by diseases of the central nervous system, addressing conditions with no effective medicinal treatment currently available. As of January 2016, SanBio introduced a product for the treatment of chronic motor impairment from ischemic stroke and traumatic brain injury into clinical development in both Japan and the US. With plans to expand indications and geographical regions for its products, the company has attracted a Post-IPO Equity investment from Nissay Capital as of 01 January 2020.
SanBio, Inc.
Founded 2013
Mountain View, United States
21 employees
Post Ipo Equity
Total: $3.17B
Agriculture, Biopharma +2
Mountain View, United States
21 employees
Post Ipo Equity
Total: $3.17B
Agriculture, Biopharma +2
General Information
Get notified when SanBio, Inc. moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track SanBio, Inc.
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
United States Market
Agriculture
About SanBio, Inc.
Funding Rounds & Investors (6)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Post-IPO Equity | •••••• | 1 |
|
01 Jan 2020 |
| Post-IPO Equity | •••••• | 1 | •••• •••• | 01 Oct 2017 |
| Post-IPO Equity | •••••• | 1 | •••• •••• | 01 Aug 2017 |
| Grant | •••••• | 1 | •••• •••• | 05 Jul 2017 |
| Post-IPO Equity | •••••• | 1 | •••• •••• | 01 Mar 2017 |
SanBio, Inc. Alternatives & Competitors
SanBio, Inc. vs
Empowering medical advancements through regenerative medicine and organoid technology for precise di...
Series A
Biopharma, Biotechnology
SanBio, Inc. vs
TikoMed AB
Sweden
Developing game changing treatments and cell therapies for severe diseases.
Series Unknown
7 employees
Biotechnology, Health and Wellness
SanBio, Inc. vs
InGeneron
United States
Unlocking Regenerative Cell Therapy
Series Unknown
18 employees
Biotechnology, Health Care
FAQ About SanBio, Inc.
Founded in February 2001 SanBio's scope of business is development, production and sales of regenerative cell medicines. Our mission is to develop regenerative medicines, creating benefits for patients and value for stakeholders. Our vision is to achieve global leadership in the regenerative medicin...
SanBio, Inc. was founded in 2013.
SanBio, Inc. is headquartered in Mountain View, United States.
SanBio, Inc. operates in the following industries: Agriculture, Biopharma, Biotechnology, Pharmaceutical.
SanBio, Inc. has approximately 21 employees.
SanBio, Inc. has completed 6 funding rounds, raising a total of $3.17B. The latest funding stage is Post Ipo Equity.
Top alternatives and competitors to SanBio, Inc. include Danwang Medical, TikoMed AB, InGeneron, 向榮生技UnicoCell Biomed, Diagonal Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
SanBio, Inc. and Danwang Medical are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Don't just browse. Track.
Signal Tracker monitors SanBio, Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.